Ensign Peak Advisors’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.49M | Sell |
35,761
-2,351
| -6% | -$295K | 0.01% | 672 |
|
|
2025
Q1 | $5.22M | Buy |
38,112
+16,443
| +76% | +$2.25M | 0.01% | 626 |
|
|
2024
Q4 | $3.31M | Sell |
21,669
-2,442
| -10% | -$373K | 0.01% | 762 |
|
|
2024
Q3 | $4.67M | Sell |
24,111
-10,470
| -30% | -$2.03M | 0.01% | 642 |
|
|
2024
Q2 | $8.02M | Buy |
34,581
+7,505
| +28% | +$1.74M | 0.01% | 509 |
|
|
2024
Q1 | $5.84M | Sell |
27,076
-57,387
| -68% | -$12.4M | 0.01% | 582 |
|
|
2023
Q4 | $21.9M | Sell |
84,463
-130,009
| -61% | -$33.6M | 0.04% | 288 |
|
|
2023
Q3 | $55.1M | Sell |
214,472
-120,836
| -36% | -$31.1M | 0.12% | 158 |
|
|
2023
Q2 | $95.5M | Buy |
335,308
+6,915
| +2% | +$1.97M | 0.19% | 102 |
|
|
2023
Q1 | $91.3M | Buy |
328,393
+98,583
| +43% | +$27.4M | 0.2% | 103 |
|
|
2022
Q4 | $63.6M | Buy |
229,810
+157,068
| +216% | +$43.5M | 0.14% | 142 |
|
|
2022
Q3 | $19.4M | Buy |
72,742
+40,076
| +123% | +$10.7M | 0.05% | 277 |
|
|
2022
Q2 | $6.66M | Sell |
32,666
-37,400
| -53% | -$7.63M | 0.02% | 460 |
|
|
2022
Q1 | $14.8M | Buy |
70,066
+10,415
| +17% | +$2.19M | 0.03% | 343 |
|
|
2021
Q4 | $14.3M | Sell |
59,651
-59,105
| -50% | -$14.2M | 0.03% | 394 |
|
|
2021
Q3 | $33.6M | Sell |
118,756
-24,794
| -17% | -$7.02M | 0.07% | 223 |
|
|
2021
Q2 | $49.7M | Buy |
143,550
+27,117
| +23% | +$9.39M | 0.1% | 178 |
|
|
2021
Q1 | $32.6M | Sell |
116,433
-25,768
| -18% | -$7.21M | 0.07% | 235 |
|
|
2020
Q4 | $34.8M | Sell |
142,201
-1,008
| -0.7% | -$247K | 0.08% | 219 |
|
|
2020
Q3 | $40.6M | Sell |
143,209
-43,424
| -23% | -$12.3M | 0.1% | 168 |
|
|
2020
Q2 | $49.9M | Sell |
186,633
-92,105
| -33% | -$24.6M | 0.14% | 132 |
|
|
2020
Q1 | $88.2M | Buy |
278,738
+2,436
| +0.9% | +$771K | 0.3% | 78 |
|
|
2019
Q4 | $82M | Buy |
+276,302
| New | +$82M | 0.22% | 89 |
|